Medicamento experimental focado na proteína tau demonstrou diminuição inédita da patologia cerebral em estudo clínico de Fase 2

An experimental drug might help slow early Alzheimer's disease in a markedly different way than current treatments — by lowering the brain's production of a protein called tau.

An experimental drug might help slow early Alzheimer's disease in a markedly different way than current treatments — by lowering the brain's production of a protein called tau